Stay updated on Selpercatinib in RET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, representing a platform software upgrade. No study content, terminology, or essential page functionality appears to be altered by this change.
    Difference
    0.0%
    Check dated 2026-07-21T12:47:27.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision label was updated from Revision: v3.6.0 to Revision: v3.6.3, indicating a minor platform/content-management update.
    Difference
    0.0%
    Check dated 2026-06-30T01:06:54.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The study record now shows that recruitment is no longer open to participants, indicating that enrollment is closed. New reader guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the recruitment locations were updated to reflect Sariyer, Turkey, with a prior location removed, signaling changes to how participants can locate sites.
    Difference
    0.2%
    Check dated 2026-06-15T18:50:22.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The revision tag in the page footer was updated from v3.5.4 to v3.5.5. This signals a minor behind-the-scenes update to the site.
    Difference
    0.0%
    Check dated 2026-06-08T17:00:48.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Location data for a site in Ukraine was updated to use the official Kharkiv Oblast designation. The address line now reads Kharkiv, Kharkiv Oblast, Ukraine, 61070, replacing the previous Kharkivs’ka Oblast’ variant.
    Difference
    0.0%
    Check dated 2026-06-01T14:19:20.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    A new publication reference has been added under Publications, citing a 2026 J Clin Oncol article about selpercatinib and postprogression therapies. This update enriches the study record with additional related literature tied to the trial.
    Difference
    0.0%
    Check dated 2026-05-25T14:32:43.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.